Know Cancer

or
forgot password

Whole Body Magnetic Resonance Imaging With Diffusion Weighted Imaging : Potential Role in Neurofibromatosis


N/A
6 Years
50 Years
Open (Enrolling)
Both
Whole Body Imaging, Magnetic Resonance Imaging, Neurofibromatosis 1, Diffusion Magnetic Resonance Imaging, Peripheral Nerve Sheath Tumors, Malignant

Thank you

Trial Information

Whole Body Magnetic Resonance Imaging With Diffusion Weighted Imaging : Potential Role in Neurofibromatosis


Inclusion Criteria:



- Patients with neurofibromatosis type 1, between 6 and 50 years old

Exclusion Criteria:

- Patients who are not allowed to be scanned on MRI (contra-indications: pacemaker ed.)

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Estimation of total tumor load and diagnosis of high-risk neurofibromas

Outcome Description:

Estimation of the total tumor load of neurofibromas with whole body MRI (head to knee). Diagnosis of high risk neurofibroma in the chest, abdomen, pelvis, and extremities with T2-weighted sequence and diffusion weighted sequence.

Outcome Time Frame:

1 month

Safety Issue:

No

Principal Investigator

Steven Pans, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Universitaire Ziekenhuizen Leuven

Authority:

Belgium: Federal Agency for Medicinal Products and Health Products

Study ID:

NEFIMAR

NCT ID:

NCT01777451

Start Date:

December 2010

Completion Date:

January 2014

Related Keywords:

  • Whole Body Imaging
  • Magnetic Resonance Imaging
  • Neurofibromatosis 1
  • Diffusion Magnetic Resonance Imaging
  • Peripheral Nerve Sheath Tumors, Malignant
  • Whole Body Imaging
  • Magnetic Resonance Imaging
  • Neurofibromatosis 1
  • Diffusion Magnetic Resonance Imaging
  • Peripheral Nerve Sheath Tumors, Malignant
  • Neoplasms
  • Neurofibromatoses
  • Neurofibromatosis 1
  • Osteitis Fibrosa Cystica
  • Nerve Sheath Neoplasms
  • Neurofibrosarcoma
  • Neurilemmoma

Name

Location